These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25311742)

  • 1. Integrating genomics into prognostic models for AML.
    Sanchez M; Levine RL; Rampal R
    Semin Hematol; 2014 Oct; 51(4):298-305. PubMed ID: 25311742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
    Madanat YF; Kalaycio ME; Nazha A
    Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
    Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
    Lin PH; Li HY; Fan SC; Yuan TH; Chen M; Hsu YH; Yang YH; Li LY; Yeh SP; Bai LY; Liao YM; Lin CY; Hsieh CY; Lin CC; Lin CH; Lien MY; Chen TT; Ni YH; Chiu CF
    Cancer Med; 2017 Feb; 6(2):349-360. PubMed ID: 28070990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics and genomics of acute myeloid leukemia.
    Snaith O; Poveda-Rogers C; Laczko D; Yang G; Morrissette JJD
    Best Pract Res Clin Haematol; 2024 Mar; 37(1):101533. PubMed ID: 38490763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
    de Noronha TR; Mitne-Neto M; Chauffaille ML
    J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
    DiNardo C; Lachowiez C
    Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
    Martelli MP; Sportoletti P; Tiacci E; Martelli MF; Falini B
    Blood Rev; 2013 Jan; 27(1):13-22. PubMed ID: 23261068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Precision medicine for acute myeloid leukemia based on genomic profiling].
    Sanada M
    Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic tools in acute myeloid leukemia: From the bench to the bedside.
    White BS; DiPersio JF
    Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational implications of somatic genomics in acute myeloid leukaemia.
    Meyer SC; Levine RL
    Lancet Oncol; 2014 Aug; 15(9):e382-94. PubMed ID: 25079101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.
    Wang RQ; Chen CJ; Jing Y; Qin JY; Li Y; Chen GF; Zhou W; Li YH; Wang J; Li DW; Zhao HM; Wang BH; Wang LL; Wang H; Wang MZ; Gao XN; Yu L
    Cancer Med; 2020 Nov; 9(22):8457-8467. PubMed ID: 32970934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?
    Patel JP; Levine RL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():28-34. PubMed ID: 23233557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in AML: prognostic and therapeutic implications.
    DiNardo CD; Cortes JE
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):348-355. PubMed ID: 27913501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mutations in acute myeloid leukemia that influence clinical decisions.
    Chung SS
    Curr Opin Hematol; 2014 Mar; 21(2):87-94. PubMed ID: 24445361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
    Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
    J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.